153 related articles for article (PubMed ID: 25649906)
1. Simultaneous treatment with statins and aspirin reduces the risk of prostate cancer detection and tumorigenic properties in prostate cancer cell lines.
Olivan M; Rigau M; Colás E; Garcia M; Montes M; Sequeiros T; Regis L; Celma A; Planas J; Placer J; Reventós J; de Torres I; Doll A; Morote J
Biomed Res Int; 2015; 2015():762178. PubMed ID: 25649906
[TBL] [Abstract][Full Text] [Related]
2. The risk of prostate cancer for men on aspirin, statin or antidiabetic medications.
Nordström T; Clements M; Karlsson R; Adolfsson J; Grönberg H
Eur J Cancer; 2015 Apr; 51(6):725-33. PubMed ID: 25727881
[TBL] [Abstract][Full Text] [Related]
3. Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression.
Kochuparambil ST; Al-Husein B; Goc A; Soliman S; Somanath PR
J Pharmacol Exp Ther; 2011 Feb; 336(2):496-505. PubMed ID: 21059805
[TBL] [Abstract][Full Text] [Related]
4. Clinical, Cellular, and Molecular Evidence of the Additive Antitumor Effects of Biguanides and Statins in Prostate Cancer.
Jiménez-Vacas JM; Herrero-Aguayo V; Montero-Hidalgo AJ; Sáez-Martínez P; Gómez-Gómez E; León-González AJ; Fuentes-Fayos AC; Yubero-Serrano EM; Requena-Tapia MJ; López M; Castaño JP; Gahete MD; Luque RM
J Clin Endocrinol Metab; 2021 Jan; 106(2):e696-e710. PubMed ID: 33247590
[TBL] [Abstract][Full Text] [Related]
5. Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial cells at therapeutic concentrations.
Murtola TJ; Pennanen P; Syvälä H; Bläuer M; Ylikomi T; Tammela TL
Prostate; 2009 Jun; 69(9):1017-23. PubMed ID: 19301305
[TBL] [Abstract][Full Text] [Related]
6. Statins reduce the androgen sensitivity and cell proliferation by decreasing the androgen receptor protein in prostate cancer cells.
Yokomizo A; Shiota M; Kashiwagi E; Kuroiwa K; Tatsugami K; Inokuchi J; Takeuchi A; Naito S
Prostate; 2011 Feb; 71(3):298-304. PubMed ID: 20717902
[TBL] [Abstract][Full Text] [Related]
7. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
Grytli HH; Fagerland MW; Fosså SD; Taskén KA
Eur Urol; 2014 Mar; 65(3):635-41. PubMed ID: 23351721
[TBL] [Abstract][Full Text] [Related]
8. Statin use and risk of prostate cancer: a Danish population-based case-control study, 1997-2010.
Jespersen CG; Nørgaard M; Friis S; Skriver C; Borre M
Cancer Epidemiol; 2014 Feb; 38(1):42-7. PubMed ID: 24275259
[TBL] [Abstract][Full Text] [Related]
9. Effect of statins and anticoagulants on prostate cancer aggressiveness.
Alizadeh M; Sylvestre MP; Zilli T; Van Nguyen T; Guay JP; Bahary JP; Taussky D
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1149-53. PubMed ID: 22270166
[TBL] [Abstract][Full Text] [Related]
10. Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.
Yli-Hemminki TH; Laurila M; Auvinen A; Määttänen L; Huhtala H; Tammela TL; Kujala PM
BJU Int; 2013 Oct; 112(6):735-41. PubMed ID: 23746332
[TBL] [Abstract][Full Text] [Related]
11. Does positive family history of prostate cancer increase the risk of prostate cancer on initial prostate biopsy?
Elshafei A; Moussa AS; Hatem A; Ethan V; Panumatrassamee K; Hernandez AV; Jones JS
Urology; 2013 Apr; 81(4):826-30. PubMed ID: 23434102
[TBL] [Abstract][Full Text] [Related]
12. Role of serum cholesterol and statin use in the risk of prostate cancer detection and tumor aggressiveness.
Morote J; Celma A; Planas J; Placer J; de Torres I; Olivan M; Carles J; Reventós J; Doll A
Int J Mol Sci; 2014 Aug; 15(8):13615-23. PubMed ID: 25101846
[TBL] [Abstract][Full Text] [Related]
13. Active surveillance of very-low-risk prostate cancer in the setting of active treatment of benign prostatic hyperplasia with 5α-reductase inhibitors.
Shelton PQ; Ivanowicz AN; Wakeman CM; Rydberg MG; Norton J; Riggs SB; Teigland CM
Urology; 2013 May; 81(5):979-84. PubMed ID: 23523297
[TBL] [Abstract][Full Text] [Related]
14. Biologic and epidemiologic evidence assessing if statins prevent prostate cancer.
Dawe DE; Mahmud S
Can J Urol; 2017 Dec; 24(6):9081-9088. PubMed ID: 29260632
[TBL] [Abstract][Full Text] [Related]
15. Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins.
Vainio P; Lehtinen L; Mirtti T; Hilvo M; Seppänen-Laakso T; Virtanen J; Sankila A; Nordling S; Lundin J; Rannikko A; Orešič M; Kallioniemi O; Iljin K
Oncotarget; 2011 Dec; 2(12):1176-90. PubMed ID: 22202492
[TBL] [Abstract][Full Text] [Related]
16. Statins and prostate cancer prevention: where we are now, and future directions.
Murtola TJ; Visakorpi T; Lahtela J; Syvälä H; Tammela TLj
Nat Clin Pract Urol; 2008 Jul; 5(7):376-87. PubMed ID: 18542103
[TBL] [Abstract][Full Text] [Related]
17. Aspirin use in relation to risk of prostate cancer.
Leitzmann MF; Stampfer MJ; Ma J; Chan JM; Colditz GA; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1108-11. PubMed ID: 12376516
[TBL] [Abstract][Full Text] [Related]
18. The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease.
Lafeber M; Spiering W; van der Graaf Y; Nathoe H; Bots ML; Grobbee DE; Visseren FL
Am Heart J; 2013 Aug; 166(2):282-289.e1. PubMed ID: 23895811
[TBL] [Abstract][Full Text] [Related]
19. Statins increase the risk of prostate cancer: a population-based case-control study.
Chang CC; Ho SC; Chiu HF; Yang CY
Prostate; 2011 Dec; 71(16):1818-24. PubMed ID: 21480313
[TBL] [Abstract][Full Text] [Related]
20. Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.
Platz EA; Rohrmann S; Pearson JD; Corrada MM; Watson DJ; De Marzo AM; Landis PK; Metter EJ; Carter HB
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):390-6. PubMed ID: 15734963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
